Since Barger and Dale (1910) described the chemical structure and sympathomimetic action of adrenaline-like amines, adrenaline and adrenergic drugs have been extensively used for the treatment of asthma. Adrenaline itself is active only when it is given parenterally or by inhalation, whereas the more recently introduced isoprenaline is more stable and can be given by inhalation or as a sublingual tablet, though it is not suitable for parenteral use. Over the past two decades the number of inhalants that have been available for the treatment of asthma has increased enormously. They consist basically of adrenaline or isoprenaline; many proprietary brands also contain other ingredients-for example, atropine sulphate, atropine methonitrate, benzocaine, papaverine, posterior pituitary extract, stramonium, as well as other trace ingredients.
In recent years inhalation therapy has become more practical as a result of technical advances in the administration of dry fine particulate aerosols, which are stored under pressure in small cartridges and delivered in metered doses. (Kennedy, 1953) , was used to assess ventilatory capacity before and at intervals after drug administration.
Results: Magnitude of Initial Response
The magnitude of the initial bronchodilator effect of five (A-E (a) The two different brands of isoprenaline showed remarkably similar response curves, with a peak effect at 15 minutes; at 90 minutes the curves were almost back to their pretreatment level. The slight difference in the magnitude in the two isoprenaline curves was probably related to the dose of isoprenaline administered.
(b) The adrenaline bitartrate curve and the adrenaline hydrochloride plus benzocaine curve mimicked each other closely. Each had a peak effect at 15 minutes, and the effect was fairly well sustained up to the 90-minute mark. The better response after adrenaline hydrochloride compared with adrenaline bitartrate may be related to the higher dose of adrenaline hydrochloride administered and/or to the addition of 1% benzocaine included with it.
(c) Although the response at 15 minutes after the inhalation of atropine methonitrate alone was less than the response achieved at this time from any of the other inhalants, the atropine methonitrate curve continued to climb throughout the period of observation and was at its highest 210 minutes after the inhalation.
(d) The combined inhalation of isoprenaline and atropine methonitrate showed substantial advantages over the other drugs. At 15 minutes the response was as good as the best isoprenaline response; it continued to improve for 120 minutes, after which the response was maintained for the duration of observation (210 minutes).
(e) The inhalation of aerosol adrenaline hydrochloride with benzocaine 210 minutes after all the test inhalants resulted in a further substantial increase in the indirect M.B.C. The 
Further Duration of Effect Studies
In view of the findings of Altounyan (1964) that asthmatics in the acute phase respond poorly to atropine, a second group of 12 asthmatic individuals who suffered from a more stable form of asthma than the previous group were tested in a similar manner with five of the six test inhalants (the adrenaline bitartrate, inhalant E, was not used). As in the first group,-the second group were selected on the basis of their consistent response to aerosol adrenaline; the majority would have been labelled by some authorities as suffering from " chronic bronchitis." The percentage change of the indirect M.B.C. of this second group, assessed at intervals after treatment with the various inhalants, is shown in Fig. 3 .
In this further study the isoprenaline-atropine mixture gave the best results, and the responses to isoprenaline alone and to adrenaline hydrochloride were also very similar to those previously obtained. (Kennedy, 1961 therapy is in itself interesting in that it may provide additional evidence concerning the mechanism of the breathing defect. There is a small group of individuals who are consistently made worse by an adrenaline inhalation.
The distinctive time-response curves of various adrenergic agents which are given by mouth have already been described (Kennedy and Jackson, 1963) , and it is interesting that in this present investigation the various adrenergic inhalants also have quite distinctive time-response curves. Although the magnitude of the immediate effect (five minutes after the inhalations) of the four dry aerosols and the one wet aerosol described in this communication is of roughly the same order, the addition of atropine afforded a greater increase in the average M.B.C. after a latent period of 30 to 60 minutes. Thus the relative merits of different inhalants should be judged on their time-response curves and the absence of side-effects. As regards duration of effect, the studies on the two groups of individuals show that isoprenaline has the shortest action, adrenaline bitartrate and adrenaline hydrochloride are intermediate, and atropine methonitrate has the most sustained effect. In addition, the time-response curves show that the combined administration of isoprenaline and atropine methonitrate give an enhanced response which is sustained better than the other inhalants. Altounyan (1964) showed that whereas atropine methonitrate afforded the best protection against carbachol challenge, it was significantly less effective than adrenergic compounds against histamine and antigen challenge. It also showed that atropine has little or no effect in acute asthma. The findings of Chamberlain, Muir, and Kennedy (1962) that atropine methonitrate is a bronchodilator in its own right are fully confirmed in this communication.
Post-mortem examination of cases of status asthmaticus have shown partial or complete occlusion of the bronchi with thick sputum plugs (Williams and Leopold, 1959 From these observations it was found that the immediate effect of the adrenergic drugs was similar.
To obtain a measure of the duration of effect of the different inhalants, serial assessments were continued for three and a half hours after each inhalant therapy on two groups of asthmatic subjects containing 12 subjects in each group. From these serial studies it was found that the inhalants gave distinct time-response curves.
The duration of isoprenaline was shortest; its action had been completely lost by 90 minutes. Adrenaline bitartrate and adrenaline hydrochloride combined with benzocaine were similar: a peak effect occurred at 15 minutes and was maintained up to 90 minutes, after which response gradually waned. Atropine methonitrate was found to have some immediate effect; the response reached a maximum at 90 minutes and was usually maintained throughout the three and a half hours of observation. The inhalation of isoprenaline in combination with atropine methonitrate showed substantial advantages over the other drugs tested. At 15 minutes the response was as good as the best isoprenaline response; it continued to improve for 120 minutes, after which it was maintained at this level during the three and a half hours of observation.
It is recommended that the frequency of administration of atropine methonitrate with or without adrenergic inhalants should be strictly controlled, especially in acute asthma.
Porto-pulmonary bilharziasis often presents as hepatosplenomegaly and cor pulmonale (Zaky, 1952 ; Zaky et al., 1959) . The haemodynamic changes in this disease have already been discussed (Foda, 1959; Zaky et al., 1962) . We found that in about 10% of these cases hypoxia of less than 94% was present. This hypoxia could not be corrected by 100% 02 inhalation.
When the alveolar CO2 tension was matched simultaneously against the arterial CO2 tension either at rest or on moderate exercise, a significant gradient was found between the alveolar Pco2 and the arterial Pco2, the latter being raised from 2 to 7 mm. Hg. Studies of pulmonary function in these cases revealed almost normal findings (Ashba, 1959) , particularly the minute alveolar ventilation and the helium-mixing time. These findings can only mean a veno-arterial admixture either inside the lung from pre-capillary pulmonary-artery/pulmonary-vein shunting or from the portal-vein blood to the pulmonary vein. In order to elucidate the above findings it was decided to carry out further investigations using the gas krypton-85.
Materials and Methods
Krypton-85 is a very interesting gas in that it is cleared by the alveoli to the extent of 95-99% in one circulation. We followed the method described by Fritts et al. (1960) to investigate the problem of a pre-capillary pulmonary-artery/ pulmonary-vein shunting. By this method a gas solute is injected with a known quantity of a blue dye into the superior vena cava and both are recovered from the brachial artery within the period of one circulation. The concentration of dye is obtained from spectrophotometer readings, while the radioactivity is read on the scaler. The percentage of shunt is calculated from the formula: 85Kr counts in integrated radialxconc. of dye injected mg.11. x100 85Kr counts injected x conc. of dye in integrated radial mg./I.
The pulmonary-artery concentrations after injection into the superior vena cava were calculated from the radiological size of the heart after the method of Hanson (1961) , and the ratio of the right to the left cavities was considered to be 55-45%. This gave the cardiac volume in which the dilution of superiorvena-cava injection could have taken place.
To investigate the problem of portal-vein/pulmonary-vein shunting, the same amount of krypton-85 was injected into the splenic pulp in bolus form; the bilharzial spleen lends itself admirably for the purpose as it is easily accessible and firm. We had no trouble while using this route in our case apart from a moderate degree of pain after the injection. Samples were collected simultaneously from the pulmonary artery and the radial artery at approximately 10-second intervals for the first minute after the injection and at every 30 seconds for the next three to five minutes. The samples were then sealed in mica cuvettes and counted through an appropriate 
